Back to dashboard
MedicaidCoverageMedium impact

February 2026 UPMC for You and UPMC Community HealthChoices formulary update

UPMC Health Plan·PA · Pulmonology, Allergy & Immunology, Pediatrics +2 more·Pharmacy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Pulmicort Flexhaler from new distributor Rubicon Holding is no longer covered under UPMC Medicaid plans due to exclusion from the Medicaid Drug Rebate program. Prescribers must transition patients to covered alternatives like Arnuity Ellipta, Asmanex HFA, or Qvar Redihaler to avoid pharmacy denials.

Action Required

Action needed
Immediately: Providers must begin transitioning current Pulmicort Flexhaler patients to covered alternatives (Arnuity Ellipta, Asmanex HFA, Asmanex Twisthaler, Budesonide Respules, Qvar Redihaler, or Fluticasone Propionate HFA for pediatric patients). Update prescribing protocols and inform providers that Pulmicort Flexhaler from Rubicon Holding will be denied at pharmacy for UPMC Medicaid patients.